Differences in Glutathione Peroxidase (GPx) Levels  Before and After Pulmonary Tuberculosis Treatment

Ersty Marthalia Putri; Anita Liliana Susanti; Deasy Wirasiti

doi:10.47134/phms.v3i1.557

Authors

Ersty Marthalia Putri Universitas Jenderal Achmad Yani
Anita Liliana Susanti Universitas Jenderal Achmad Yani
Deasy Wirasiti Universitas Jenderal Achmad Yani

DOI:

https://doi.org/10.47134/phms.v3i1.557

Keywords:

Glutathione Peroxidase, Oxidative Stress, Pulmonary Tuberculosis, Scoping Review

Abstract

This study aimed to review changes in glutathione peroxidase or GPx levels or activity before and after pulmonary tuberculosis treatment. A systematic scoping review was conducted on articles published between 2016 and 2025 retrieved from Google Scholar, ScienceDirect, and PubMed. Article selection followed PRISMA guidelines and applied eligibility criteria based on the PICO framework. Six studies met the inclusion criteria and were included in the analysis. All reviewed studies reported changes in GPx levels or activity after tuberculosis treatment, with most showing an increase in GPx activity following anti-tuberculosis therapy. Several studies also reported that adjunct antioxidant interventions, such as N-acetylcysteine, contributed to enhanced glutathione system function and increased GPx activity compared to standard therapy alone. The observed increase in GPx activity was associated with reduced oxidative stress and improved redox balance during treatment. These findings indicate that GPx has potential as a biomarker for monitoring treatment response in pulmonary tuberculosis. However, variations in study design, sample size, and measurement methods were identified across the included studies. Further well-designed clinical studies with standardized GPx assessment protocols are needed to confirm its clinical utility and to clarify the role of antioxidant supplementation in supporting tuberculosis treatment outcomes.

References

Aggarwal, A., Singh, P., Bagati, K. D., & Mathur, S. (2025). A study on role of antioxidants in prevention of hepatotoxicity induced by antitubercular drugs. International Journal of Life Science and Biotechnology and Pharma Research, 14(7), 300–311.

Amaral, E. P., Foreman, T. W., & Namasivayam, S. (2021). Antioxidant pathways as potential therapeutic targets in tuberculosis. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.639031

Banerjee, S., Bhattacharya, D., & Mukherjee, S. (2020). Antioxidant enzyme imbalance and its clinical significance in pulmonary tuberculosis. Lung India, 37(6), 503–509. https://doi.org/10.4103/lungindia.lungindia_262_20

Behera, A., Jain, P., Ganguli, G., Biswas, M., Padhi, A., & Pattanaik, K. P. (2022). Mycobacterium tuberculosis acetyltransferase suppresses oxidative stress by inducing peroxisome formation in macrophages. International Journal of Molecular Sciences, 23(5). DOI: https://doi.org/10.3390/ijms23052584

Choi, R., Kim, H. J., Jo, Y. S., & Kim, Y. R. (2021). Changes in oxidative stress markers and antioxidant enzymes during anti-tuberculosis treatment. BMC Infectious Diseases, 21, 1021. https://doi.org/10.1186/s12879-021-06728-5

Corr, M., Waterfield, T., Fairley, D., McKenna, J., & Shields, M. D. (2020). A protocol for a systematic review and meta-analysis of the diagnostic accuracy of mid-regional pro-adrenomedullin in predicting invasive bacterial infection in children. Systematic Reviews, 9. DOI: https://doi.org/10.1186/s13643-020-01338-1

Holmes, K. K., Bertozzi, S., Bloom, B. R., & Jha, P. (2017). Disease control priorities: Major infectious diseases (Vol. 6). World Bank.

Ighodaro, O. M., & Akinloye, O. A. (2018). First line defence antioxidants—superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Journal of Medicine, 54(4), 287–293. DOI: https://doi.org/10.1016/j.ajme.2017.09.001

Ivanovich, B. Y., Petrovich, I. P., Sergiyovich, P. Y., Oleksiivna, S. O., & Oleksandrivna, G. S. (2017). Activity of the antioxidant system enzymes in patients with different clinical forms of the pulmonary tuberculosis. Health Education Research, 1517–1526.

Kundu, M., Basu, J., & Chakrabarti, P. (2022). Redox regulation of host–pathogen interactions in Mycobacterium tuberculosis infection. Cellular Microbiology, 24(2). https://doi.org/10.1111/cmi.13377 DOI: https://doi.org/10.1111/cmi.13377

Leblanc, V., Hamroun, A., Bentegeac, R., Le Guellec, B., Lenain, R., & Chazard, E. (2023). Added value of MeSH terms in search strategies of systematic reviews. Journal of Medical Internet Research. DOI: https://doi.org/10.2196/53781

Leo, S., Narasimhan, M., Rathinam, S., & Banerjee, A. (2024). Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: A review. Annals of Medicine, 56(1). DOI: https://doi.org/10.1080/07853890.2024.2386030

Mahakalkar, S., Nagrale, D., Gaur, S., Urade, C., Murhar, B., & Turankar, A. (2017). N-acetylcysteine as an add-on to directly observed therapy short-I therapy in fresh pulmonary tuberculosis patients: A randomized, placebo-controlled, double-blinded study. Perspectives in Clinical Research, 8(3), 132–136. DOI: https://doi.org/10.4103/2229-3485.210450

Matuku-Kisaumbi, P. (2024). Improving societal systems to end tuberculosis (pp. 1–10). IntechOpen.

Meng, F., Zhou, K., Bu, Y., Huang, W. B., Zhang, P., & Long, F. (2022). Keywords extraction and thesaurus construction for domain news. Procedia Computer Science, 214, 837–844. DOI: https://doi.org/10.1016/j.procs.2022.11.249

Mengist, W., Soromessa, T., & Legese, G. (2020). Ecosystem services research in mountainous regions: A systematic literature review on current knowledge and research gaps. Science of the Total Environment, 702. DOI: https://doi.org/10.1016/j.scitotenv.2019.134581

Organization, W. H. (2024). Global tuberculosis report 2024.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., & Mulrow, C. D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ, 372. DOI: https://doi.org/10.31222/osf.io/v7gm2_v1

Pizzino, G., Irrera, N., & Cucinotta, M. (2020). Oxidative stress, inflammation, and lung diseases: The role of antioxidant systems. Antioxidants, 9(8). https://doi.org/10.3390/antiox9080728 DOI: https://doi.org/10.3390/antiox9080728

Ratnani, I., Fatima, S., Abid, M. M., Surani, Z., & Surani, S. (2023). Evidence-based medicine: History, review, criticisms, and pitfalls. Cureus, 15(2). DOI: https://doi.org/10.7759/cureus.35266

Safe, I. P., Amaral, E. P., Araújo-Pereira, M., Lacerda, M. V. G., Printes, V. S., & Souza, A. B. (2021). Adjunct N-acetylcysteine treatment in hospitalized patients with HIV-associated tuberculosis dampens the oxidative stress in peripheral blood: Results from the RIPENACTB study trial. Frontiers in Immunology, 11. DOI: https://doi.org/10.3389/fimmu.2020.602589

Santra, S., Bishnu, D., Dhali, G. K., Santra, A., & Chowdhury, A. (2020). Expression of type I collagen in response to isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: An in-vitro study. PLOS One, 15(7). DOI: https://doi.org/10.1371/journal.pone.0236992

Singh, M., Vaughn, C., Sasaninia, K., Yeh, C., Mehta, D., & Khieran, I. (2020). Understanding the relationship between glutathione, TGF-β, and vitamin D in combating Mycobacterium tuberculosis infections. Journal of Clinical Medicine, 9. DOI: https://doi.org/10.3390/jcm9092757

Tenny, S., & Varacallo, M. A. (2025). Evidence-based medicine. National Institutes of Health.

Toossi, Z., Wu, M., & Hirsch, C. S. (2021). Distinct oxidative stress signatures in active tuberculosis and their modulation during treatment. Tuberculosis, 127. https://doi.org/10.1016/j.tube.2020.102055

Venketaraman, V., Millman, A., & Salman, M. (2020). Glutathione levels and immune responses in tuberculosis patients. Journal of Clinical Medicine, 9(6). https://doi.org/10.3390/jcm9061897 DOI: https://doi.org/10.3390/jcm9061897